Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue Authors
Received: 22 November 1993 Accepted: 17 January 1994 DOI:
Cite this article as: Prasad, K.N., Carvalho, E., Kentroti, S. et al. In Vitro Cell Dev Biol - Animal (1994) 30: 596. doi:10.1007/BF02631258 Summary
This investigation reports for the first time the establishment of immortalized clones of dopamine-producing nerve cells in culture. Freshly prepared single-cell suspensions from fetal (12-day-old) rat mesencephalic tissue were transfected with plasmid vectors, pSV3neo and pSV5neo, using an electroporation technique. Cells were plated in tissue culture dishes which were precoated with a special substrate and contained modified MCDB-153 growth medium with 10% heat inactivated fetal bovine serum. The immortalized cells were selected by placing the transfected cells in a selection medium (modified MCDB-153 containing 400
µg/ml geneticin). The survivors showed the presence of T-antigens and were non-tumorigenic. Two cell lines, 1RB 3 derived from cells transfected with pSV 3neo, and 2RB 5 derived from cells transfected with pSV 3neo, revealed only 1 to 2% tyrosine hydroxylase (TH)-positive cells. Repeated single-cell cloning of these cell lines by a standard technique failed to increase the number of TH-positive cells in any clones. Using three cycles of growth, alternating between hormone-supplemented, serum-free medium and serum-containing medium produced a cell line (1RB3A) that was very rich in TH-positive cells. The recloning of 1RB3A yielded clones some of which contained over 95% TH-positive cells. These cells produced homovanillic acid, a metabolite of dopamine, and may be useful not only for neural transplant but also for basic neurobiological studies. Key words immortalization dopamine-producing cells homovanillic acid T-antigens tyrosine hydroxylase References
Allen, G. S.; Burns, R. S.; Tulpan, N. B., et al. Adrenal medullary transplantation to the caudate nucleus in Parkinson’s disease: initial clinical results in 18 patients. Arch. Neurol. 46:487–491; 1989.
Bakay, R. A. E.; Barrow, D. L.; Fiandaca, M. S., et al. Biochemical and behavioral correction of MPTP-like syndrome by fetal cell transplantation. Ann. NY Acad. Sci. 495:623–640; 1987.
Bartelett, P. F.; Reid, H. H.; Bailey, K. A., et al. Immortalization of mouse neural precursor cells by the c-
oncogene. Proc. Natl. Acad. Sci. USA 85:3255–3259; 1988.
Bernard, O.; Reid, H. H.; Bartlett, P. F. Role of the c-
and the N-
oncogenes in the immortalization of neural precursors. J. Neurosci. Res. 24:9–20; 1989.
Bjorklund, A.; Stenevi, U. Reconstruction of the nigrostriatial dopamine pathway by intracerebral nigral transplants. Brain Res. 177:555–560; 1979.
Bohn, M. C.; Cupit, L.; Marciano, F., et al. Adrenal medulla graft enhanced recovery of striatal dopaminergic fibers. Science 237:913–916; 1987.
Bottenstein, J. E.; Sato, G. H. Growth of a rat neuroblastoma cell line in serum free supplemented medium. Proc. Natl. Acad. Sci. USA 76:514–517; 1979.
Choi, H. K.; Won, I. A.; Kontur, P. I., et al. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552:67–76; 1991.
Dunnett, S. B.; Annett, L. E. Nigral transplants in primate model of Parkinsonism. In: Lindvall, O., Bjorklund, A., Widner, H., eds. Intracerebral transplantation in movement disorders, vol. 4. Restorative neurology and neuroscience. Amsterdam: Elsevier; 1991:27–51.
Dunnett, S. B.; Hernandez, T.; Summerfield, A., et al. Graft-derived recovery from 6-0HDA lesions: specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71:411–424; 1988.
Evrard, C.; Borde, I.; Marin, P., et al. Immortalization of bipotential and plastic glia—neuronal precursor cells. Proc. Natl. Acad. Sci. USA 87:3062–3066; 1990.
Freed, C. R.; Breeze, R. E.; Rosenberg, N. L., et al. Transplantation of human fetal dopamine cells for Parkinson’s disease. Arch. Neurol. 47:505–512; 1990.
Freed, C. R.; Breeze, T. E.; Rosenberg, N. L., et al. Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson’s disease. N. Engl. J. Med. 327:1549–1555; 1992.
Freed, W. J.; Poltorak, N.; Becker, J. B. Intracerebral adrenal medulla grafts: a review. Exp. Neurol. 110:39–166; 1990.
Galiana, E.; Borde, I.; Marin, P., et al. Establishment of permanent astroglia cell lines, able to differentiate in vitro, from transgenic mice carrying the polyoma virus large T-gene: An alternative approach to brain cell immortalization. J. Neurosci. Res. 26:269–277; 1990.
Gash, D. M.; Collier, T. J.; Sladek, J. R., Jr. Neural transplantation: a review of recent developments and potential application to aged brain. Neurobiol. Aging 6:131–150; 1985.
Goetz, C. G.; Olanow, C. W.; Koller, W. C., et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson’s disease. N. Engl. J. Med. 320:337–341; 1989.
Henderson, B. T. H.; Clough, C. G.; Hughes, R. C., et al. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson’s disease. Arch. Neurol. 48:822–827; 1991.
Kentroti, S.; Vernadakis, A. Growth hormone—releasing hormone influences neural expression in the developing chick brain. I. Catecholaminergic neurons. Dev. Brain Res. 49:275–280; 1989.
Kordower, J. H.; Fiandaca, M. S.; Notter, M. F. D., et al. Scientific basis for dopaminergic brain grafting. In: Koller, W. C.; Paulson, G., eds. Therapy of Parkinson’s disease. New York: Marcel Dekker, Inc.; 1990:443–472.
La Rosa, F. G.; Talmage, D. W. Major histocompatability complex antigen expression on parenchymal cells of thyroid allografts is not by itself sufficient to induce rejection. Transplantation 49:605–609; 1990.
Lechner, J. F.; LaVeek, M. A. A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J. Tissue Cult. Methods 9:43–48; 1985.
Lindvall, O.; Rehncrona, S.; Brundin, P., et al. Human fetal dopamine neurons grafted into striatum in two patients with severe Parkinson’s disease. Arch. Neurol. 46:615–631; 1989.
Lindvall, O.; Backlund, E-O.; Farde L., et al. Transplantation in Parkinson’s disease: two cases of adrenal medullary grafts to the putamen. Ann. Neurol. 22:457–468; 1987.
Lindvall, O.; Brundin, P.; Widner, H., et al. Graft of fetal dopamine neurons survive and improve motor function in Parkinson’s disease. Science 247:547–577; 1990.
Lindvall, O.; Widner, H.; Rehncrona, S., et al. Transplantation of fetal dopamine neurons in Parkinson’s disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155–165; 1992.
Lowry, O. H.; Rosebrough, N. J.; Farr, A. L., et al. Protein measurement with Folin Phenol reagent. J. Biol. Chem. 193:265–275; 1951.
Madrazo, I.; Leon, V.; Torres, C., et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease. N. Engl. J. Med. 318:51; 1988.
Madrazo, I.; Drucker-Colin, R.; Diaz, B., et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N. Engl. J. Med. 316:831–834; 1987.
Madrazo, I.; Franco-Bourland, R.; Ostrosky-Solis, F., et al. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinsonian subjects. Arch. Neurol. 48:1281–1285; 1990.
Masserano, J. M.; Takimoto, A. S.; Weiner, N. Tyrosine hydroxylase activity in the brain and adrenal gland of rats following chronic administrations of ethanol. Alcohol Clin. Exp. Res. 7:294–298; 1983.
Mugele, K.; Kugler, H.; Spiess, J. Immortalization of a fetal rat brain cell line that expresses corticotropin releasing factor mRNA. DNA Cell Biol. 12:119–126; 1993.
Prasad, K. N. Differentiation of neuroblastoma cells: a useful model for neurobiology and cancer. Biol. Rev. 66:431–451; 1991.
Prasad, K. N.; Carvalho, E.; Kentroti, S., et al. Production of terminally differentiated neuroblastoma cells in culture. Rest. Neurol. Neurosci. In press; 1994.
Prasad, K. N.; Kentroti, S.; Edwards-Prasad, J., et al. Modification of the expression of adenosine 3′, 5′-cyclic monophosphate—induced differentiated functions in neuroblastoma cells by beta-carotene and d-alpha-tocopheryl succinate. J. Am. Coll. Nutr. (In press); 1994.
Perlow, M. J.; Freed, W. J.; Hoffer, B. J., et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643–647; 1979.
Pirisi, L.; Yasumoto, S.; Feller, M., et al. Transformation of human fibroblasts and keratinocytes with human papilloma virus type 16 DNA. J. Virol. 61:1061–1066, 1987.
Sawle, G. V.; Bloomfield, P. M.; Bjorklund, A., et al. Transplantation of fetal dopamine neurons in Parkinson’s disease: PET (
-fluorodopa studies in two patients with putaminal implants. Ann. Neurol. 31:166–173; 1992.
Southern, P. J.; Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327–341; 1982.
Sternberger, L. A.; Hardy, P. H., Jr.; Cuculis, J. J., et al. Unlabeled antibody-enzyme method of immunocytochemistry. Preparations and properties of soluble antigen-antibody complex (horse radish peroxidase-anti-horse radish peroxidase) and its use in the identification of spirochetes. J. Histochem. Cytochem. 18:315–333; 1970.
Tandon, P. N.; Gopinath, G.; Mahapatra, A. K., et al. Neural transplantation in mammals: our experience. Proc. Indian Acad. Sci. B56:551–558; 1990.
Widner, H.; Brundin, P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res. Rev. 13:287–324; 1988.
Yurek, D.; Sladek, J. R., Jr. Dopamine cell replacement: Parkinson’s disease. Ann. Rev. Neurosci. 13:415–440; 1989.
CrossRef Copyright information
© Society for In Vitro Biology 1994